NCT02574091View on ClinicalTrials.gov

Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 26, 2015

Primary Completion Date

February 19, 2017

Study Completion Date

February 19, 2017

Conditions
Psoriasis
Interventions
DRUG

1% icotinib hydrochloride cream

Topical administration for twice daily

DRUG

2% icotinib hydrochloride cream

Topical administration for twice daily.

DRUG

Placebo

Topical administration for twice daily.

Trial Locations (1)

Unknown

Christchurch Clinical Studies Trust, Christchurch

Sponsors
All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

Betta Pharmaceuticals Co., Ltd.

INDUSTRY